北京费森尤斯卡比医药有限公司
企业 · Beijing, China · LEI 529900TBGVBUMFIIMA05
LEI active
Summary
北京费森尤斯卡比医药有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 911100006000562780. Its legal form is 企业 – enterprise (China). According to GLEIF, its ultimate parent is Fresenius SE & Co. KGaA (Germany), which is also its direct parent. That group has 95 subsidiaries with LEIs in 42 countries, 4 of them in China. The LEI was first issued on 26 Sep 2018 and the record was last updated on 10 Sep 2026; the next renewal is due by 10 Oct 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | 企业 enterprise (China) |
|---|---|
| Register | National Enterprise Credit Information Publicity System · Register website |
| Registration number | 911100006000562780 |
| Registration authority | State Administration for Market Regulation |
| Jurisdiction | China |
| Registered address | No. 57, Huatuo Road, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, 101400 Beijing, China |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 18 Jul 1994 |
| LEI | 529900TBGVBUMFIIMA05 |
| LEI status | active |
| LEI first issued | 26 Sep 2018 |
| LEI record last updated | 10 Sep 2026 |
| Next LEI renewal | 10 Oct 2027 |
| Corroboration of the LEI record | partly corroborated |
Group membership
北京费森尤斯卡比医药有限公司 this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Fresenius SE & Co. KGaA | Fresenius SE & Co. KGaA |
| Accounting period | 1 Jan 2025 to 31 Dec 2025 | 1 Jan 2025 to 31 Dec 2025 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 29 Jul 2021 | 14 Sep 2018 |
| Recorded at GLEIF since | 31 Aug 2021 | 26 Sep 2018 |
| Last updated | 10 Sep 2026 | 10 Sep 2026 |
| Record status | current | current |
Other subsidiaries of the same direct parent (92)
- 费森尤斯卡比华瑞制药有限公司 China
- 费森尤斯卡比（中国）投资有限公司 China
- 费森尤斯卡比（南昌）医疗器械有限公司 China
- "FRESENIUS KABI POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Poland
- AUDERE MEDICAL SERVICES LIMITED United Kingdom
- AVENSYS UK GROUP LIMITED United Kingdom
- AVENSYS UK LTD United Kingdom
- AVENSYS UK TRAINING LIMITED United Kingdom
- Calea Ltd. Canada
- CALEA UK LIMITED United Kingdom
- CLINICO MEDICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Poland
- CÔNG TY CỔ PHẦN FRESENIUS KABI VIỆT NAM Vietnam
Other names
- Beijing Fresenius Kabi Pharmaceuticals Co., Ltd. · previous name
- Beijing Fresenius Kabi Pharmaceuticals Co., Ltd. · name in another language
- Beijing Fresenius Kabi Pharmaceutical Co., Ltd. · previous name
History
10 Oct 2025Legal name changed
13 Aug 2024Legal name changed
11 Aug 2023Legal form changed